Immunotherapy: why screening patients is key


About the research

Immunotherapy is increasingly being used in the fight against cancer. But this therapy does not work for all patients. You would think that if it doesn't work, it doesn't it hurt. Unfortunately, it does! Marlies Vanden Bempt (VIB - KU Leuven) explains why in this video.

Marlies Vanden Bempt
KU Leuven - VIB

Marlies Vanden Bempt graduated from the KU Leuven as Bio-engineer in 2013, and started her doctoral research in the lab of Jan Cools in the VIB Center for Cancer Biology. Her research focused on discovering the mechanisms of leukemia development in children. Now she works as research coordinator of one of the VIB Grand Challenge programs, with the aim to identify which cancer patients will respond to immune therapy. She loves to present her scientific results to every researcher that dares to pass, but she is equally interested in bringing science into the lives of young and old non-scientists. She went to primary schools to bring science to young children already 3 times, and she presented her research on national television in ‘Iedereen Beroemd’. 

Gerelateerde video's